Doris Rau

Person

Munich, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Nucleic acids encoding anitbody constructs binding EGFR VIII and CD3
- Patent number 12,152,078
- Issue date Nov 26, 2024
- Amgen Research (Munich) GmbH
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cross-species-specific single domain bispecific single chain antibody
- Patent number 11,987,633
- Issue date May 21, 2024
- Amgen Research (Munich) GmbH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions comprising cross-species-specific antibodies and uses...
- Patent number 11,925,684
- Issue date Mar 12, 2024
- Amgen Research (Munich) GmbH
- Roman Kischel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody constructs for MSLN and CD3
- Patent number 11,884,720
- Issue date Jan 30, 2024
- Amgen Research (Munich) GmbH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody constructs for CDH19 and CD3
- Patent number 11,498,964
- Issue date Nov 15, 2022
- Amgen Research (Munich) GmbH
- Shouhua Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cross-species-specific PSMAxCD3 bispecific single chain antibody
- Patent number 11,472,886
- Issue date Oct 18, 2022
- Amgen Research (Munich) GmbH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for treating glioblastoma or glioma with antibody constructs...
- Patent number 11,155,629
- Issue date Oct 26, 2021
- Amgen Research (Munich) GmbH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antibody constructs for CDH3 and CD3
- Patent number 11,028,171
- Issue date Jun 8, 2021
- Amgen Research (Munich) GmbH
- Bertram Weiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cross-species-specific single domain bispecific single chain antibody
- Patent number 10,981,998
- Issue date Apr 20, 2021
- Amgen Research (Munich) GmbH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Binding molecules for BCMA and CD3
- Patent number 10,766,969
- Issue date Sep 8, 2020
- Amgen Inc.
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Binding molecules for BCMA and CD3
- Patent number 10,752,694
- Issue date Aug 25, 2020
- Amgen Inc.
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody constructs for EGFRVIII and CD3
- Patent number 10,519,241
- Issue date Dec 31, 2019
- Amgen Research (Munich) GmbH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody constructs for CDH19 and CD3
- Patent number 10,059,766
- Issue date Aug 28, 2018
- Amgen Inc.
- Shouhua Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions with resistance to soluble CEA
- Patent number 9,982,063
- Issue date May 29, 2018
- Amgen Research (Munich) GmbH
- Ralf Lutterbüse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions with resistance to soluble CEA
- Patent number 9,695,250
- Issue date Jul 4, 2017
- Amgen Research (Munich) GmbH
- Ralf Lutterbüse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Binding molecules for BCMA and CD3
- Patent number 9,598,500
- Issue date Mar 21, 2017
- Amgen Inc.
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cross-species-specific PSMAxCD3 bispecific single chain antibody
- Patent number 9,587,036
- Issue date Mar 7, 2017
- Amgen Research (Munich) GmbH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Binding molecules for BCMA and CD3
- Patent number 9,340,621
- Issue date May 17, 2016
- Boehringer Ingelheim International GmbH
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Binding molecules for BCMA and CD3
- Patent number 9,150,664
- Issue date Oct 6, 2015
- Amgen Research (Munich) GmbH
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical antibody compositions with resistance to soluble CEA
- Patent number 8,901,278
- Issue date Dec 2, 2014
- Amgen Research (Munich) GmbH
- Doris Rau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions with resistance to soluble CEA
- Patent number 8,394,926
- Issue date Mar 12, 2013
- Micromet AG
- Ralf Lutterbüse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Composition comprising cross-species-specific antibodies and uses t...
- Patent number 8,236,308
- Issue date Aug 7, 2012
- Micromet AG
- Roman Kischel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODY CONSTRUCTS FOR MSLN AND CD3
- Publication number 20240400673
- Publication date Dec 5, 2024
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibody Constructs for CDH19 and CD3
- Publication number 20240010724
- Publication date Jan 11, 2024
- Amgen Inc.
- Shouhua Xiao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYPEPTIDE CONSTRUCTS BINDING TO CD3
- Publication number 20230406929
- Publication date Dec 21, 2023
- Amgen Inc.
- Doris Rau
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CROSS-SPECIES-SPECIFIC BINDING DOMAIN
- Publication number 20230357444
- Publication date Nov 9, 2023
- AMGEN RESEARCH (MUNICH) GMBH
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
- Publication number 20230037742
- Publication date Feb 9, 2023
- AMGEN RESEARCH (MUNICH) GMBH
- Peter KUFER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY CONSTRUCTS FOR CDH3 AND CD3
- Publication number 20230041876
- Publication date Feb 9, 2023
- AMGEN RESEARCH (MUNICH) GMBH
- Bertram Weiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING MOLECULES FOR BCMA AND CD3
- Publication number 20220356268
- Publication date Nov 10, 2022
- Amgen Inc.
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING MOLECULES FOR BCMA AND CD3
- Publication number 20220251243
- Publication date Aug 11, 2022
- Amgen Inc.
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR TREATING GLIOBLASTOMA OR GLIOMA WITH ANITBODY CONSTRUCTS...
- Publication number 20220064308
- Publication date Mar 3, 2022
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BINDING MOLECULES FOR BCMA AND CD3
- Publication number 20220064336
- Publication date Mar 3, 2022
- Amgen Inc.
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CROSS-SPECIES-SPECIFIC SINGLE DOMAIN BISPECIFIC SINGLE CHAIN ANTIBODY
- Publication number 20220041736
- Publication date Feb 10, 2022
- AMGEN RESEARCH (MUNICH) GMBH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
- Publication number 20210277143
- Publication date Sep 9, 2021
- AMGEN RESEARCH (MUNICH) GMBH
- Peter KUFER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
- Publication number 20210269550
- Publication date Sep 2, 2021
- AMGEN RESEARCH (MUNICH) GMBH
- Peter KUFER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD...
- Publication number 20200362039
- Publication date Nov 19, 2020
- AMGEN RESEARCH (MUNICH) GMBH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY CONSTRUCTS FOR EGFRVIII AND CD3
- Publication number 20200140558
- Publication date May 7, 2020
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS
- Publication number 20200095319
- Publication date Mar 26, 2020
- AMGEN RESEARCH (MUNICH) GMBH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY CONSTRUCTS FOR CDH19 AND CD3
- Publication number 20200071405
- Publication date Mar 5, 2020
- AMGEN RESEARCH (MUNICH) GMBH
- Shouhua Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
- Publication number 20190169310
- Publication date Jun 6, 2019
- AMGEN RESEARCH (MUNICH) GMBH
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS COMPRISING CROSS-SPECIES-SPECIFIC ANTIBODIES AND USES...
- Publication number 20190070290
- Publication date Mar 7, 2019
- AMGEN RESEARCH (MUNICH) GMBH
- Roman Kischel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY CONSTRUCTS FOR CDH19 AND CD3
- Publication number 20190016805
- Publication date Jan 17, 2019
- AMGEN RESEARCH (MUNICH) GMBH
- Shouhua Xiao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODY CONSTRUCTS FOR CDH3 AND CD3
- Publication number 20180142021
- Publication date May 24, 2018
- AMGEN RESEARCH (MUNICH) GMBH
- Bertram Weiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS WITH RESISTANCE TO SOLUBLE CEA
- Publication number 20170137538
- Publication date May 18, 2017
- AMGEN RESEARCH (MUNICH) GMBH
- Ralf Lutterbüse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY CONSTRUCTS FOR MSLN AND CD3
- Publication number 20170029502
- Publication date Feb 2, 2017
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY CONSTRUCTS FOR EGFRVIII AND CD3
- Publication number 20170029512
- Publication date Feb 2, 2017
- AMGEN RESEARCH (MUNICH)
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BINDING MOLECULES FOR BCMA AND CD3
- Publication number 20160176973
- Publication date Jun 23, 2016
- AMGEN RESEARCH (MUNICH) GMBH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS
- Publication number 20160152707
- Publication date Jun 2, 2016
- AMGEN RESEARCH (MUNICH) GMBH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY CONSTRUCTS FOR CDH19 AND CD3
- Publication number 20150368343
- Publication date Dec 24, 2015
- AMGEN RESEARCH (MUNICH) GMBH
- Shouhua Xiao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BINDING MOLECULES FOR BCMA AND CD3
- Publication number 20150023967
- Publication date Jan 22, 2015
- Amgen Research (Munich) GmbH
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING MOLECULES FOR BCMA AND CD3
- Publication number 20140348837
- Publication date Nov 27, 2014
- Amegen Research (Munich) GmbH
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibody Constructs for CDH19 and CD3
- Publication number 20140322218
- Publication date Oct 30, 2014
- AMGEN RESEARCH (MUNICH) GMBH
- Shouhua Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Nucleic acids encoding anitbody constructs binding EGFR VIII and CD3

Cross-species-specific single domain bispecific single chain antibody

Compositions comprising cross-species-specific antibodies and uses...

Antibody constructs for MSLN and CD3

Antibody constructs for CDH19 and CD3

Cross-species-specific PSMAxCD3 bispecific single chain antibody

Method for treating glioblastoma or glioma with antibody constructs...

Bispecific antibody constructs for CDH3 and CD3

Cross-species-specific single domain bispecific single chain antibody

Binding molecules for BCMA and CD3

Binding molecules for BCMA and CD3

Antibody constructs for EGFRVIII and CD3

Antibody constructs for CDH19 and CD3

Pharmaceutical compositions with resistance to soluble CEA

Pharmaceutical compositions with resistance to soluble CEA

Binding molecules for BCMA and CD3

Cross-species-specific PSMAxCD3 bispecific single chain antibody

Binding molecules for BCMA and CD3

Binding molecules for BCMA and CD3

Pharmaceutical antibody compositions with resistance to soluble CEA

Pharmaceutical compositions with resistance to soluble CEA

Composition comprising cross-species-specific antibodies and uses t...

Patents Applicationslast 30 patents

ANTIBODY CONSTRUCTS FOR MSLN AND CD3

Antibody Constructs for CDH19 and CD3

POLYPEPTIDE CONSTRUCTS BINDING TO CD3

CROSS-SPECIES-SPECIFIC BINDING DOMAIN

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

BISPECIFIC ANTIBODY CONSTRUCTS FOR CDH3 AND CD3

BINDING MOLECULES FOR BCMA AND CD3

BINDING MOLECULES FOR BCMA AND CD3

METHOD FOR TREATING GLIOBLASTOMA OR GLIOMA WITH ANITBODY CONSTRUCTS...

BINDING MOLECULES FOR BCMA AND CD3

CROSS-SPECIES-SPECIFIC SINGLE DOMAIN BISPECIFIC SINGLE CHAIN ANTIBODY

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD...

ANTIBODY CONSTRUCTS FOR EGFRVIII AND CD3

CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS

ANTIBODY CONSTRUCTS FOR CDH19 AND CD3

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

COMPOSITIONS COMPRISING CROSS-SPECIES-SPECIFIC ANTIBODIES AND USES...

ANTIBODY CONSTRUCTS FOR CDH19 AND CD3

BISPECIFIC ANTIBODY CONSTRUCTS FOR CDH3 AND CD3

PHARMACEUTICAL COMPOSITIONS WITH RESISTANCE TO SOLUBLE CEA

ANTIBODY CONSTRUCTS FOR MSLN AND CD3

ANTIBODY CONSTRUCTS FOR EGFRVIII AND CD3

BINDING MOLECULES FOR BCMA AND CD3

CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS

ANTIBODY CONSTRUCTS FOR CDH19 AND CD3

BINDING MOLECULES FOR BCMA AND CD3

BINDING MOLECULES FOR BCMA AND CD3

Antibody Constructs for CDH19 and CD3